2022年肾脏疾病随机对照试验集萃

doi:10.3969/j.issn.1006-298X.2023.01.011

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (1): 49-52.DOI: 10.3969/j.issn.1006-298X.2023.01.011

2022年肾脏疾病随机对照试验集萃

出版日期:2023-02-28 发布日期:2023-02-23

Highlights of randomized controlled trials on kidney disease in 2022

Online:2023-02-28 Published:2023-02-23

摘要/Abstract

摘要： 2022年,肾脏病领域取得了很多重要进展,其中随机对照试验(RCT)仍是临床关注的焦点。本文主要总结2022年肾脏病领域的重要RCT研究结果。

关键词: 随机对照试验, 肾脏疾病

Abstract: In 2022, a lot of important progress has been made in the field of kidney disease, among which the randomized controlled trial (RCT) is still the focus of clinical attention. This paper mainly summarizes the important RCT research results in the field of kidney disease in 2022.

Key words: randomized controlled trial, kidney disease

黄湘华, 章海涛, 刘志红. 2022年肾脏疾病随机对照试验集萃[J]. 肾脏病与透析肾移植杂志, 2023, 32(1): 49-52.

HUANG Xianghua, ZHANG Haitao, LIU Zhihong. Highlights of randomized controlled trials on kidney disease in 2022[J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2023, 32(1): 49-52.

ISSN 1006-298X CN 32-1425/R

2022年肾脏疾病随机对照试验集萃

Highlights of randomized controlled trials on kidney disease in 2022

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价